Legal Representation
Attorney
Henry Schanzer
USPTO Deadlines
Next Deadline
54 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
March 09, 2026
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 9, 2026 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jan 9, 2026 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 3, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Oct 3, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 3, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 26, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 25, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 25, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 11, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 19, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Mar 19, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Mar 9, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Mar 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 9, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Nutritional supplements
First Use Anywhere:
Mar 1, 2025
First Use in Commerce:
Mar 5, 2025
Additional Information
Pseudo Mark
DR NAD VITALITY BLE MD
Pseudo Mark
DR NICOTINAMIDE ADENINE DINUCLEOTIDE VITALITY BLEMD
Pseudo Mark
DOCTOR NAD VITALITY BLEMD
Pseudo Mark
DOCTOR NICOTINAMIDE ADENINE DINUCLEOTIDE BLEMD
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
DR NAD